Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary aim is to investigate the effectiveness of Emotion Regulation Individual Therapy for Adolescents (ERITA) who self-harm.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Emotion Regulation Individual Therapy for Adolescents | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Emotion Regulation Individual Therapy for Adolescents | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| Deliberate Self-Harm Inventory - 9 item version | Change from baseline in self-harming behaviors when measures weekly, after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Borderline Symptom List Behavior supplement (BSL-supplement) | Change from baseline in self-destructive and risky behaviors when measures weekly, after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Euroqol-5D (EQ-5D) | Change from Baseline in quality of life after 14 weeks and at 6- and 12 months after treatment has Change from baseline in quality of life after 12 weeks and at 6 months after treatment has ended. Used for health economic evaluations. | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Karolinska Institutet | Stockholm | 113 64 | Sweden |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29282024 | Derived | Bjureberg J, Sahlin H, Hellner C, Hedman-Lagerlof E, Gratz KL, Bjarehed J, Jokinen J, Tull MT, Ljotsson B. Emotion regulation individual therapy for adolescents with nonsuicidal self-injury disorder: a feasibility study. BMC Psychiatry. 2017 Dec 28;17(1):411. doi: 10.1186/s12888-017-1527-4. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016728 | Self-Injurious Behavior |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Difficulties in Emotion Regulation Scale -16 item version (DERS-16) | Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up |
| Diary questionnaire (DQ) | Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up |
| Difficulties in Emotion Regulation Scale (DERS) | Change from baseline in difficulties in emotion regulation after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up |
| Strengths and Difficulties Questionnaire Child and Parent version (SDQ-C/P) | Change from baseline in strengths and difficulties after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up |
| Borderline personality features in childhood (BPFS-C) | Change from baseline in borderline personality features after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up |
| The alcohol use disorders identification test - C (AUDIT-C) | Change from baseline in alcohol use after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up |
| Evaluation of the Drug Use Disorders Identification Test - C (DUDIT-C) | Change from baseline in drug use after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up |
| Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness - Child version (TiC-P) |
Change from Baseline in societal costs after 14 weeks and at 6- and 12 months after treatment has Change from baseline in quality of life after 12 weeks and at 6 months after treatment has ended. Used for health economic evaluations. |
| Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up |
| Patient Health Questionnaire (PHQ9) | Change in patient parent health from baseline after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up |
| General Anxiety Disorder (GAD7) | Change in patient parent health from baseline after 12 weeks and at 6 months after treatment has ended. | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up |
| The treatment credibility scale | Perceived treatment credibility | One week after treatment start |
| Working Alliance Inventory (WAI) short version | Perceived working alliance | Three weeks after treatment start |